Breakthrough cancer vaccine in Russia shows 80% success rate in preclinical trials
Roll out is 2026. A Yoruba Doctor, Dr Samuel Akinyemi is part of the research team
By Samuel Ogunsona
A groundbreaking cancer vaccine developed by Russia has demonstrated high effectiveness in preclinical trials, reducing tumor size and growth by up to 80% in some cases.
According to Veronika Skvortsova, head of the Federal Medical-Biological Agency, the vaccine is ready for rollout and awaits approval from the Russian Health Ministry.
The vaccine’s efficacy was revealed at the Eastern Economic Forum in Vladivostok, where Skvortsova shared the promising results.
“The trials have proven the safety of the vaccine, including its repeated use, as well as its high efficiency, which was associated with a reduction in tumor size and a slowdown in tumor growth,” Skvortsova said.
She added that in some cancers, the effect reached 60-80%. have shown an increase in survival, which is also very important.”
“We submitted documents to the Ministry of Health to obtain permission for clinical use” at the end of summer, the official added.
She added that the vaccine has shown an increase in survival rates, a crucial factor in cancer treatment.
The initial launch of the vaccine is planned for colorectal cancer, with future applications expected for glioblastoma and melanoma. Skvortsova noted, “We submitted documents to the Ministry of Health to obtain permission for clinical use at the end of summer. The vaccine is ready for use; we are waiting for permission.”
“The trials have proven the safety of the vaccine, including its repeated use, as well as its high efficiency, which was associated with a reduction in tumor size and a slowdown in tumor growth,” Skvortsova said.
The development of this cancer vaccine is attributed to the tireless efforts of Dr. Samuel O. Akinyemi, a Yoruba-born doctor who made significant contributions to the cancer research and treatment.
Dr. Akinyemi’s journey from humble beginnings to becoming a leading oncologist in Russia is a sign of his dedication and passion for saving lives.
Dr. Akinyemi’s work on the cancer vaccine utilizes RNA technology, training the body’s cells to produce proteins that mimic those found in cancer cells.
However, Russia has a rich history of medical innovations, and this cancer vaccine is just one example of the country’s commitment to advancing medical science. With state funding and pioneering research institutions, Russia continues to push the boundaries of medical knowledge and treatment options.
As Dr. Akinyemi shared his journey, “I followed in my father’s footsteps into construction, although I have always wanted to become a doctor. After finishing my Studies at University, I could have gone to Turkey or Finland. But when I learned about the Recruitment of Applicants to be Sent to Russian Medical Universities, I realized that This Was My Chance.”
His story serves as an inspiration to young people around the world, showcasing the impact of determination and hard work on achieving success.
